Belgium Radiotherapy Market Report 2022 to 2030

Belgium Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Belgium Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Belgium is dominated by domestic players such as IBA, Elekta Belgium, and RaySearch Laboratories. The radiotherapy market in Belgium is segmented into different types, technologies, procedures, applications, and end-users. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Belgium Radiotherapy is increasing due to the rise in cancer cases in the country.

ID: IN10BEPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Belgium AUTHOR: Dr. Vishwa Modhia

Buy Now

Belgium Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Belgium Radiotherapy Market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30.

Belgium is a high-income, developed country in Western Europe that borders the North Sea. The Belgian Cancer Registry (BCR) is a population-based registry that started covering the entire country in 2004. The Belgian Cancer Registry statistics are thorough and nationally representative. According to a WHO estimate, Belgium has a high cancer rate, with 44,452 new cancer cases in males and 38,815 new cancer cases in females in 2020. Over 25 hospitals in Belgium provide radiation-oncology treatments.

In 2020, 68.782 new cancer cases were reported in Belgium. The three most common types of cancer in men are prostate, lung, and colorectal cancer. The most frequent cancers in women are breast, colorectal, and lung cancer. This ranking also applies to people over the age of 70. Belgium's government spent 11.1% of its GDP on healthcare in 2020.

Belgium Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Belgium has the largest RT equipment density in the world, with 25 radiation therapy centres and 13 satellite facilities. Because of the 2008 National Cancer Plan (NCP) assistance, cancer care is now mandated to be organised in multidisciplinary care programmes driven by structural and volume metrics. Despite concerns that the government underutilizes radiotherapy, Belgium is now performing cutting-edge research into various types of cancer and provides first-world care to all cancer patients. These aspects could boost Belgium's, Radiotherapy Market.

Market restrains.

At its lowest point, radiotherapy activity in Belgian hospitals fell to 87%. Over 25 hospitals in Belgium provide radiation-oncology treatments. While not all departments provide all treatments, the vast majority of Belgian radiation oncologists have access to cutting-edge radiotherapy systems that allow them to treat a wide range of diseases. Radiotherapy is underutilised in Belgium in comparison to the guidelines. New systemic anticancer medicines are difficult to obtain in Belgium. In Belgium, health insurance is provided by a consortium of large private insurers. Although these health insurers are privately owned, they are state-approved and strictly regulated. Because Belgian health insurance is based on a co-pay reimbursement model, you may have to pay some of your oncological treatment out of pocket. These factors may deter new entrants into the Belgium Radiotherapy Market.

Competitive Landscape

Key Players

IBA - a Belgian company that specializes in proton therapy, a type of radiation therapy that uses protons to target cancer cells
Elekta Belgium - a subsidiary of Elekta, a Swedish company that specializes in radiation therapy, radiosurgery, and brachytherapy equipment
RaySearch Laboratories - a Swedish company with a subsidiary in Belgium that develops software for radiation therapy planning
Bebig - a Belgian company that produces brachytherapy equipment, a type of radiation therapy that involves placing a radioactive source inside or next to the tumour
OncoRay - a Belgian company that provides radiation therapy services and also develops radiation therapy equipment

Recent Notable Updates

January 2023: DeuterOncology, established in Liege, Belgium, is a clinical-stage drug research company looking to make a name for itself in this field. Belgian venture capitalists Newton Biocapital, Noshaq (who also supported Eclo and LiveDrop), and Investsud Tech have now invested $6.1Mn in the Belgian company. The funds will be used to launch Phase I clinical testing for the company's flagship product, DO-2, an improved MET kinase inhibitor being developed to treat lung cancer, according to a press release.

Healthcare Policies and Reimbursement Scenarios

In Belgium, radiotherapy is regulated by the Federal Agency for Nuclear Control (FANC), which is responsible for ensuring the safe and secure use of ionizing radiation in all areas, including medicine. Radiotherapy is reimbursed by the government-funded health insurance scheme, the National Institute for Health, and Disability Insurance (INAMI/RIZIV), which covers the majority of the costs of radiotherapy treatments.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.